Learn how physicians and medical professionals can stay up to date health policy, health care reform and more with timely and insightful commentary from health policy leaders.
This JAMA Forum discusses 4 focus areas developed by a collaborative of more than 40 organizations and experts in health care, social services, and other sectors designed to find ways to support and address social determinants of health with better program coordination and partnerships and novel financing approaches.
This JAMA Forum discusses the philosophy and ethics of population health, approaches that may improve the health of populations, ideas for improving decision-making for better health outcomes, and the partnerships needed to improve population health.
This JAMA Forum discusses the ongoing debate in Mississippi about whether to expand Medicaid under the Patient Protection and Affordable Care Act.
This JAMA Forum discusses 5 consequences of disenrolling individuals from Medicaid after the end of the pause in checking eligibility that was enacted during the emergency phase of the COVID-19 pandemic.
This JAMA Forum discusses the responsibilities of public health agencies that overlap with those of the US Centers for Disease Control and Prevention (CDC) and argues that the role of the CDC could be redirected to better meet the needs of its core mission鈥攊nfectious disease control.
This JAMA Forum discusses former President Donald Trump鈥檚 current viewpoints and prior policies on price transparency, drug pricing, and the Affordable Care Act that could be reflected in his health care policy if reelected.
This JAMA Forum discusses the epidemiological and theoretical explanations regarding the erosion of the Latino health advantage in the US and proposes policies to promote Latino immigrant health.
This JAMA Forum discusses modifications to US health policy, including variation in coverage generosity, improving ease of use, and reimagining community health centers and public hospitals, which could be made to build on the near-universal multitiered health care system now in place.
This JAMA Forum discusses recent rulings made by the US Supreme Court that limit the decision-making power of government agencies to safeguard public health, ensure safety, and protect the environment.
This JAMA Forum discusses key government efforts to advance the availability of healthy school meals, the evidence of the effects of these efforts, and the role for health professionals.
This JAMA Forum discusses the issues surrounding medical debt in the US and reflects on policy efforts made in recent years to solve some of the root causes.
This JAMA Forum discusses new regulatory requirements for antidiscrimination in artificial intelligence tools used in health care, the dark side of flexible enforcement by agencies, and ways to facilitate meaningful compliance.
This JAMA Forum discusses health strategies that could be used to reduce juvenile crime, including identifying and treating trauma with behavioral health, rethinking the punishment approach, and incorporating other methods to overcome current challenges.
This JAMA Forum discusses the cost of newly approved weight loss medications in the US compared with other countries and provides arguments for why these medications should be more available for individuals in the US and covered by more insurers.
This JAMA Forum discusses the current data collection mechanisms used for Medicare and proposes ways to improve nationwide data collection efforts for Medicaid.
This JAMA Forum discusses patient- and population-level nonadherence to medical advice and elaborates on 4 main categories of reasons that underpin nonadherence.
This JAMA Forum discusses aspects of individual coverage health reimbursement arrangements and their expanded use over the last few years.
This JAMA Forum discusses 3 key steps for restructuring the acquisition of health data to enable more timely access to the data and more timely public health action, similar to the successes seen with the COVID-19 pandemic response in the US.
This JAMA Forum discusses pending legislation in the US House and Senate and the history of the 鈥渇irm-based approach鈥 the US Food and Drug Administration (FDA) could use when regulating artificial intelligence (AI) medical devices to augment patient care.
This JAMA Forum discusses the effects of certificate of need laws, certificates of public advantage laws, and restrictions on physician-owned hospitals under the Affordable Care Act on hospital expansion and renovation and health care costs.
Customize your 糖心vlog experience by selecting one or more topics from the list below.